CHICAGO – Improved radiotherapy techniques have made it possible for men to achieve reductions in PSA to below detectable levels following radiation treatment for prostate cancer, according to new ...

Eric Morrow is no stranger to unexpected journeys. News4 caught up with the prostate cancer survivor and Air Force veteran as he headed off on a lifechanging trip. “I wouldn’t wish cancer on anyone, ...

In real-world practice, the faster and deeper the PSA response to apalutamide plus ADT in men with mHSPC, the better the survival rate. Overall survival rates are higher for men experiencing deep and ...

Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation in Resected Stage III Melanoma: A Phase III Randomized Controlled Trial of Health-Related Quality of Life and Symptoms by the ...

SYDNEY, Nov. 30, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity", "the Company"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products ...

A new study by researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy shows promise for a monoclonal antibody, enoblituzumab, as a safe and ...

During a live event, Tian Zhang, MD, MHS, discussed darolutamide in mHSPC, with efficacy and cost being key considerations ...

SAN ANTONIO -- More than 2 years after treatment, no patient with high-risk prostate cancer had a confirmed biochemical recurrence after receiving postoperative apalutamide (Erleada) and androgen ...

Jan. 01, 2009 -- Question: How do I know if salvage therapy is effective? Answer: After your salvage therapy, you and your doctor will keep a close eye on things. You'll get checkups every 3-6 months ...